Dabur India Ltd
⚠️ High Risk
FEI: 3007168274 • New Delhi, Delhi • INDIA
FEI Number
3007168274
Location
New Delhi, Delhi
Country
INDIAAddress
8/3 Asaf Ali Road, , New Delhi, Delhi, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
DIETARYLBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
INCONSPICU
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
COSM COLOR
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a color additive which is unsafe within the meaning of Section 721(a) which renders it adulterated under Section 601(e).
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
NCONTACTS
The product is a dietary supplement that is marketed in the United States and appears to not have a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event.
PRESRV LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a chemical preservative and it fails to bear labeling stating that fact including its function.
PESTICIDE
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a pesticide chemical residue, which causes the article to be adulterated within the meaning of section 402(a)(2)(B) of the FD&C Act. Bears or contains:
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/6/2025 | 54YGA99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 241PESTICIDE | Division of Southeast Imports (DSEI) |
| 5/19/2025 | 61PDY26METFORMIN (ANTI-DIABETIC) | Division of Southeast Imports (DSEI) | |
| 5/6/2024 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/8/2023 | 65CCY99NUTRIENT/TONIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/24/2023 | 66VIY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 9/6/2022 | 53IG01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS) | Division of Northern Border Imports (DNBI) | |
| 8/17/2021 | 66VDC99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/21/2018 | 66VBA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/21/2018 | 66VBA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/21/2018 | 66VBA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/22/2016 | 66YDL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 118NOT LISTED | New York District Office (NYK-DO) |
| 8/27/2014 | 66VBY99MISCELLANEOUS PATENT MEDICINES, ETC. | San Francisco District Office (SAN-DO) | |
| 4/15/2014 | 54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Chicago District Office (CHI-DO) | |
| 4/15/2014 | 54FCR99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Chicago District Office (CHI-DO) | |
| 2/19/2013 | 54FCC99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 3681NCONTACTS | San Francisco District Office (SAN-DO) |
| 2/19/2013 | 54FCY99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 218LIST INGRE | San Francisco District Office (SAN-DO) |
| 2/19/2013 | 54FCY99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 218LIST INGRE | San Francisco District Office (SAN-DO) |
| 1/31/2013 | 54EYT99HERBALS & BOTANICAL TEAS, N.E.C. | Los Angeles District Office (LOS-DO) | |
| 8/14/2012 | 66VBK99MISCELLANEOUS PATENT MEDICINES, ETC. | Chicago District Office (CHI-DO) | |
| 4/20/2012 | 60LBY75EUGENOL (ANALGESIC) | San Francisco District Office (SAN-DO) | |
| 4/30/2008 | 36CCB04HONEY | Los Angeles District Office (LOS-DO) | |
| 4/30/2008 | 36CCB04HONEY | Los Angeles District Office (LOS-DO) | |
| 7/19/2004 | 54FER99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/19/2004 | 54FER99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/19/2004 | 54FEA99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/19/2004 | 54FEA99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/19/2004 | 53GH99OTHER MAKEUP PREPARATION, NOT FOR THE EYES, N.E.C. | Southwest Import District Office (SWI-DO) | |
| 4/22/2004 | 30GCT99BEVERAGE BASE OF NON-FRUIT ORIGIN, LIQUID, N.E.C. | Seattle District Office (SEA-DO) | |
| 1/30/2004 | 33AGT06FLAVORED CANDY, HARD (LIVE SAVERS, ETC.), WITH NUTS OR NUT PRODUCTS (NOT COCONUT OR SUCKERS)(WITHOUT | 249FILTHY | Seattle District Office (SEA-DO) |
| 11/7/2003 | 36CCB04HONEY | Southwest Import District Office (SWI-DO) | |
| 9/2/2003 | 54FEZ99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/25/2003 | 53ED07TONICS, DRESSINGS, AND OTHER HAIR GROOMING AIDS (HAIR PREPARATIONS, NON-COLORING) | 471CSTIC LBLG | Southwest Import District Office (SWI-DO) |
| 7/25/2003 | 53ED07TONICS, DRESSINGS, AND OTHER HAIR GROOMING AIDS (HAIR PREPARATIONS, NON-COLORING) | 471CSTIC LBLG | Southwest Import District Office (SWI-DO) |
| 4/1/2002 | 54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Seattle District Office (SEA-DO) | |
| 4/1/2002 | 54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Seattle District Office (SEA-DO) | |
| 4/1/2002 | 54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Seattle District Office (SEA-DO) |
Frequently Asked Questions
What is Dabur India Ltd's FDA import refusal history?
Dabur India Ltd (FEI: 3007168274) has 36 FDA import refusal record(s) in our database, spanning from 4/1/2002 to 10/6/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dabur India Ltd's FEI number is 3007168274.
What types of violations has Dabur India Ltd received?
Dabur India Ltd has been cited for 18 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Dabur India Ltd come from?
All FDA import refusal data for Dabur India Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.